IDSEP230060
Cooperative Agreement
Overview
Grant Description
Ca for IBX (ribonucleotide triphosphates (NTPs))
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
California
United States
Geographic Scope
State-Wide
Related Opportunity
EP-IDS-23-002
Analysis Notes
COVID-19 $12,666,514 (100%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the End Date has been extended from 12/31/23 to 03/31/35 and the total obligations have increased 533% from $2,000,000 to $12,666,514.
Amendment Since initial award the End Date has been extended from 12/31/23 to 03/31/35 and the total obligations have increased 533% from $2,000,000 to $12,666,514.
Trilink Biotechnologies was awarded
Efficient Catalyst for NTP Synthesis: CA for IBX
Cooperative Agreement IDSEP230060
worth $12,666,514
from the HHS Office of the Assistant Secretary for Preparedness and Response in December 2022 with work to be completed primarily in California United States.
The grant
has a duration of 12 years 3 months and
was awarded through assistance program 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development.
Status
(Ongoing)
Last Modified 3/20/25
Period of Performance
12/16/22
Start Date
3/31/35
End Date
Funding Split
$12.7M
Federal Obligation
$0.0
Non-Federal Obligation
$12.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to IDSEP230060
Additional Detail
Award ID FAIN
IDSEP230060
SAI Number
IDSEP230060-3914488139
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75APRR ASPR Office of Resource Management
Funding Office
75AN00 ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Awardee UEI
JTZNJ1K5HUA4
Awardee CAGE
3Y9Z9
Performance District
CA-90
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Defense Production Act Medical Supplies Enhancement (075-0150) | Health care services | Grants, subsidies, and contributions (41.0) | $12,666,514 | 100% |
Modified: 3/20/25